Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyanka Kanth

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|November 8, 2017
Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal NeoplasiaDon A Delker, Austin C Wood, Angela K Snow, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
JAMA|March 23, 2016
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical TrialN Jewel Samadder, Deborah W Neklason, Kenneth M Boucher, et al.
Gut|May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposisN Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Nature Cell Biology|August 17, 2017
Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolismJohn C Schell, Dona R Wisidagama, Claire Bensard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020Dawn Provenzale, Reid M Ness, Xavier Llor, et al.
The New England Journal of Medicine|September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous PolyposisCarol A Burke, Evelien Dekker, Patrick Lynch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Dawn Provenzale, Xavier Llor, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer Prevention Research (Philadelphia, Pa.)|November 8, 2017
Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal NeoplasiaDon A Delker, Austin C Wood, Angela K Snow, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
JNCI Cancer Spectrum|January 15, 2025
Rethinking the rise of early-onset gastrointestinal cancers: a call to actionBenjamin A Weinberg, Caitlin C Murphy, David R Freyer, et al.
JAMA|March 23, 2016
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical TrialN Jewel Samadder, Deborah W Neklason, Kenneth M Boucher, et al.
Gut|May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposisN Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Nature Cell Biology|August 17, 2017
Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolismJohn C Schell, Dona R Wisidagama, Claire Bensard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020Dawn Provenzale, Reid M Ness, Xavier Llor, et al.
The New England Journal of Medicine|September 9, 2020
Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous PolyposisCarol A Burke, Evelien Dekker, Patrick Lynch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019Samir Gupta, Dawn Provenzale, Xavier Llor, et al.
Gut|July 10, 2020
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosaLaura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, et al.
Pageof 6